Equity Research, Broker Reports, and media content on Allergy Therapeutics Plc

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Allergy Therapeutics Plc
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Allergy Therapeutics Plc

Company Profile

  • Personnel
  • Manuel Llobet , CEO
  • Nicolas Wykeman, Finance Director

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Allergy Therapeutics Plc. We currently have 229 research reports from 10 professional analysts.

  • Open: N/A
  • Range Today: N/A
  • 52 Week: 7.00/21.5p
  • Daily Volume: N/A
  • Daily Liquidity: (0.09%)
  • # Shares: 637.3m
  • Market Cap: £109.9m
  • Latest PE (hist): 23.36
  • Div Yield:
Date Source Announcement
23Sep20 07:00 RNS Preliminary Results
03Sep20 07:00 RNS AGY secures VLP technology platform
20Jul20 07:30 EQS Hardman & Co Research: Allergy Therapeutics (AGY): Record sales and a COVID-19 wildcard
15Jul20 11:05 RNS Second Price Monitoring Extn
15Jul20 11:00 RNS Price Monitoring Extension
15Jul20 07:00 RNS Trading Update
09Jul20 07:00 RNS Invalidation of Birch MATA MPL phase III results
  • Frequency of research reports


  • Research reports on

    Allergy Therapeutics Plc

  • Providers covering

    Allergy Therapeutics Plc